TNFRSF25 | Tumor necrosis factor receptor superfamily, member 25 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PLEKHG5 | Pleckstrin homology domain containing, family G (with RhoGef domain) member 5 | Disease related genes
| | | | | Tissue enhanced |
NOL9 | Nucleolar protein 9 | | | | | | Expressed in all |
TAS1R1 | Taste receptor, type 1, member 1 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
ZBTB48 | Zinc finger and BTB domain containing 48 | Transcription factors
| | | | | Expressed in all |
KLHL21 | Kelch-like family member 21 | | | | | | Expressed in all |
PHF13 | PHD finger protein 13 | | | | | | Expressed in all |
THAP3 | THAP domain containing, apoptosis associated protein 3 | Transcription factors
| | | | | Expressed in all |
DNAJC11 | DnaJ (Hsp40) homolog, subfamily C, member 11 | Predicted membrane proteins
| | | | | Expressed in all |
CAMTA1 | Calmodulin binding transcription activator 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
VAMP3 | Vesicle-associated membrane protein 3 | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
PER3 | Period circadian clock 3 | | | | | | Mixed |
UTS2 | Urotensin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
TNFRSF9 | Tumor necrosis factor receptor superfamily, member 9 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
PARK7 | Parkinson protein 7 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ERRFI1 | ERBB receptor feedback inhibitor 1 | | | | | | Tissue enhanced |
SLC45A1 | Solute carrier family 45, member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
RERE | Arginine-glutamic acid dipeptide (RE) repeats | Disease related genes Transcription factors
| | | | | Expressed in all |
ENO1 | Enolase 1, (alpha) | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
SLC2A7 | Solute carrier family 2 (facilitated glucose transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A5 | Solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPR157 | G protein-coupled receptor 157 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
SPSB1 | SplA/ryanodine receptor domain and SOCS box containing 1 | | | | | | Mixed |
SLC25A33 | Solute carrier family 25 (pyrimidine nucleotide carrier), member 33 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Mixed |
TMEM201 | Transmembrane protein 201 | Predicted membrane proteins
| | | | | Mixed |
PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Mixed |
C1orf200 | Chromosome 1 open reading frame 200 | | | | | | Not detected |
CLSTN1 | Calsyntenin 1 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CTNNBIP1 | Catenin, beta interacting protein 1 | | | | | | Expressed in all |
LZIC | Leucine zipper and CTNNBIP1 domain containing | | | | | | Expressed in all |
NMNAT1 | Nicotinamide nucleotide adenylyltransferase 1 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
RBP7 | Retinol binding protein 7, cellular | | | | | | Expressed in all |
UBE4B | Ubiquitination factor E4B | Plasma proteins
| | | | | Expressed in all |
KIF1B | Kinesin family member 1B | Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
PGD | Phosphogluconate dehydrogenase | Enzymes Plasma proteins
| | | | | Expressed in all |
APITD1 | Apoptosis-inducing, TAF9-like domain 1 | | | | | | Expressed in all |
APITD1-CORT | APITD1-CORT readthrough | | | | | | Tissue enhanced |
CORT | Cortistatin | Predicted secreted proteins
| | | | | Tissue enriched |
DFFA | DNA fragmentation factor, 45kDa, alpha polypeptide | Plasma proteins
| | | | | Expressed in all |
PEX14 | Peroxisomal biogenesis factor 14 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CASZ1 | Castor zinc finger 1 | Transcription factors
| | | | | Mixed |
C1orf127 | Chromosome 1 open reading frame 127 | Predicted secreted proteins
| | | | | Group enriched |
TARDBP | TAR DNA binding protein | Disease related genes Plasma proteins
| | | | | Expressed in all |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
SRM | Spermidine synthase | Enzymes
| | | | | Expressed in all |
EXOSC10 | Exosome component 10 | | | | | | Expressed in all |
MTOR | Mechanistic target of rapamycin (serine/threonine kinase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ANGPTL7 | Angiopoietin-like 7 | Predicted secreted proteins
| | | | | Tissue enhanced |